Umbilical Cord Blood Bank - Cord Blood Stem Cells News

Cord Blood Stem Cells News

Reportlinker Adds Global Stem Cells Research Industry Friday, March 12, 2010 @ 9:58AMReportlinker.com announces that a new market research report is available in its catalogue:
"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting Wednesday, March 3, 2010 @ 6:04AMCellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11.
Presentations on Geron's Telomerase Inhibitor At AACR Special Conference Tuesday, March 2, 2010 @ 6:30AMMENLO PARK, Calif.----Geron Corporation today announced several presentations at the American Association for Cancer Research Special Conference on The Role of Telomeres and Telomerase in Cancer Research held in Fort Worth, TX between February 27th and March 1st.
Cord blood: a wasted lifeline? Monday, March 1, 2010 @ 6:27PMToday, all things being about average, 2,000 babies will be born in Britain, or roughly one every 80 seconds. Almost without exception, their umbilical cords will be clamped, cut – and incinerated. And this, say a growing number of parents and health professionals, is waste so flagrant it borders on the criminal. Far from being dead on arrival, these sinewy flexes are potential lifelines long ...
Determining personal risk for genetic disorders essential Monday, March 1, 2010 @ 4:49AMGenetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the benefits of undergoing genetic testing, close to 80 percent had never talked to their physician about genetic screening – an inconsistency that can have serious implications on a ...
Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list Friday, February 26, 2010 @ 7:50AMFate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies ...
New treatments for heart disease Wednesday, February 24, 2010 @ 2:11AMTwo studies published in the latest issue of Cell Transplantation (18:12) may lead to new treatments for the treatment of heart diseases. The first study, carried out by a team of Brazilian researchers, found that cell transplantation of bone marrow mononuclear cells (BMMCs) directly into the heart benefited patients suffering from refractory angina.
AmStem Corporation Announces Ticker Symbol Change to AMST Effective Today Tuesday, February 23, 2010 @ 12:20PMTAMPA, FL--(Marketwire - February 23, 2010) - AmStem Corporation ( OTCBB : AMST ) announces that it has received approval from the Financial Industry Regulatory Authority (FINRA) for the Company's name change to AmStem Corporation from Stem Cell Therapy International and for its ticker symbol change to AMST from SCII as quoted on the Over the Counter Bulletin Board effective today, February 23 ...
Aldagen Announces Strategic Management Changes Tuesday, February 23, 2010 @ 9:35AMRichard Kent, M.D. Appointed to Chairman of the Board; Leadership Strengthened as Products Advance Through Clinical Trials
Aldagen Announces Strategic Management Changes Tuesday, February 23, 2010 @ 9:20AMDURHAM, NC--(Marketwire - 02/23/10) - Aldagen, Inc. today announced strategic management changes to better position the company as it advances clinical development of its product pipeline. Effective immediately, Richard Kent, M.D. will join Aldagen's Board of Directors and will become Chairman of the Board. Dr. Kent is a venture partner at Intersouth Partners, and has 27 years of experience in ...
Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML Friday, February 19, 2010 @ 2:05AMNovartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Health Briefs Wednesday, February 17, 2010 @ 9:46PMKaiser Permanente Southern California received the most stars - eight of a possible eight - in the overall ratings of the just released HMO Quality Report from the California Office of the Patient Advocate.
Leukemia Patient Saved By Cord Blood Says "Thank You" To Mother And Baby He Will Never Know Monday, February 15, 2010 @ 4:06PMA forty-three-year old man from Sussex, England, whose life was saved by cord blood donated by a mother and newborn baby he will never know said he will always feel grateful to them. Philip Meehan was 40 when he discovered he had leukemia. He found out after a week's walking holiday in the Lake District in 2007; he told the press that as a self-employed person the week's break was a rare chance ...
Cerebral palsy stem cell trial begins Monday, February 15, 2010 @ 3:43PMAUGUSTA, Ga., Feb. 15 (UPI) -- U.S. scientists say they are starting a clinical trial to determine whether stem cells from umbilical cord blood can help children with cerebral palsy.
Japan's Public Television Films Louisiana's LifeSource Cryobank To Feature In Documentary Series On Regenerative ... Monday, February 15, 2010 @ 8:37AMNHK Global Media Services, Inc., Japan's only public broadcasting television network visited Covington, Louisiana to film, LifeSource Cryobank, LLC. LifeSource will be featured in a documentary series on regenerative medicine to be aired next month in Japan. LifeSource Cryobank is the first private company in the United States to offer both umbilical cord blood banking and adult bone marrow stem ...
I love you, baby Saturday, February 13, 2010 @ 6:57PMThe man saved by an unknown child's umbilical cord
Rehab gym rises out of son's need Friday, February 12, 2010 @ 11:18PMBLOOMSBURG, Pa.—Dissatisfied and disheartened, Jim and Georgia Sampson brought their son, Danny, home from the hospital.
Dr. Hoon Han Elected Chairman of the Board of Stem Cell Therapy International Tuesday, February 9, 2010 @ 10:38AMTAMPA, FL--(Marketwire - February 9, 2010) - Stem Cell Therapy International, Inc. ( OTCBB : SCII ) announced that Dr. Hoon Han has been elected Chairman of the Company's Board of Directors effective immediately.
Dr. Hoon Han Elected Chairman of the Board of Stem Cell Therapy International Tuesday, February 9, 2010 @ 10:30AMTAMPA, FL--(Marketwire - 02/09/10) - Stem Cell Therapy International, Inc. (OTC.BB: SCII - News ) announced that Dr. Hoon Han has been elected Chairman of the Company's Board of Directors effective immediately. The Company also announced the resignation of Lixian (John) Jiang from all positions with the Company. Lixian (John) Jiang continues to be interested in assisting the Company in an ...
Healthcare Technology Stock Alert for ThermoGenesis Corp. Issued by StockPreacher Monday, February 8, 2010 @ 5:50AMDALLAS -- StockPreacher.com announces an investment report featuring medical-device maker ThermoGenesis Corp. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
While battling cancer, couple counts their blessings Monday, February 8, 2010 @ 3:10AMA question lingers for Geri Cochrane as she curls up next to her husband, Dave, to watch him sleep.
ICMR to hold 'public consultations' to evolve consensus on guidelines for stem cell research Sunday, February 7, 2010 @ 8:43PMNearly two years after issuing the guidelines for stem cell research regulation prescribing stringent procedures for sourcing and use of stem cells by research institutions in the country, the Indian Council of Medical Research (ICMR) will soon embark on 'public consultations' to evolve a consensus on the document among the various stakeholders.
ThermoGenesis announces distribution agreement with GE Healthcare for its AXP System Thursday, February 4, 2010 @ 11:46PMThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, today announced a new enhanced distribution agreement with GE Healthcare, a unit of General Electric Company, for its AXP® AutoXpress ™ (AXP) System used in the processing of cord blood.
ThermoGenesis Announces Major Strategic Development With Completion of New Distribution Agreement With GE Healthcare Thursday, February 4, 2010 @ 5:14PMRANCHO CORDOVA, Calif., Feb. 4 /PRNewswire-FirstCall/ -- ThermoGenesis Corp.
ThermoGenesis Announces Major Strategic Development With Completion of New Distribution Agreement With GE Healthcare Thursday, February 4, 2010 @ 3:10PMThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today announced a new enhanced distribution agreement with GE Healthcare, a unit of General Electric Company , for its AXPÂ® AutoXpress â¢ System used in the processing of cord blood. Â
ThermoGenesis Reports Significant Improvement in Sequential Financial Results for Second Quarter Fiscal 2010 Thursday, February 4, 2010 @ 3:00PMThermoGenesis Corp. , a leading supplier of innovative products and services that process and store adult stem cells, today reported results for the second quarter and first six months of fiscal 2010.
Fate Therapeutics Receives Allowance of First U.S. Patent for Induced Pluripotent Stem Cell Technology Thursday, February 4, 2010 @ 7:00AMFate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Â Upon issuance, the patent will cover foundational induced pluripotent stem cell technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency ...
Mouse model demonstrates cell-to-cell connections between implanted stem cells and diseased cells Tuesday, February 2, 2010 @ 1:31AMInvestigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), the Karolinska Institutet, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School and Universit- Libre de Bruxelles have demonstrated in mouse models that transplanted stems cells, when in direct contact with diseased neurons, send signals through ...
Stem Cell Therapy International completes merger with Histostem of South Korea Monday, February 1, 2010 @ 11:48PMStem Cell Therapy International, Inc. announced that it has completed its merger with Histostem Ltd. of South Korea ("Histostem"), forming one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a U.S. entity.
City welcomes rare catch in competitive biotech field Monday, February 1, 2010 @ 5:44PMAs a measure of investor confidence in Cord Blood America, CEO Matthew Schissler noted at the formal opening of the new Las Vegas offices and laboratory that there had been days when more than one billion shares traded.
Stem Cell Therapy International, Inc. Closes Merger With Histostem Ltd. Monday, February 1, 2010 @ 12:35PMMerger Forms One of the First Combined Pacific Rim & U.S. Stem Cell Entities
Reportlinker Adds Stem Cell Therapy for Stroke Wednesday, January 27, 2010 @ 10:08AMReportlinker.com announces that a new market research report is available in its catalogue:
Stem cell surgery saved Waynesboro girl's life Friday, January 22, 2010 @ 1:18AMStem cell transplants have been used since the 1970s to save the lives of cancer victims and children with inherited disorders of the immune systems.
Panel discussion on benefits of oral chemotherapy in cancer care Friday, January 22, 2010 @ 12:43AMUS Oncology, Inc. partnered with the Association of Community Cancer Centers, Association of Oncology Social Work, American Society for Clinical Oncology, Community Oncology Alliance, Oncology Nursing Society and the National Patient Advocate Foundation in hosting a panel discussion on Capitol Hill today to examine the benefits of oral chemotherapy in cancer care, as well as challenges in its ...
LifeSouth kicks off donation month Friday, January 22, 2010 @ 12:16AMLifeSouth Community Blood Centers want people to start their year off by saving three lives as part of National Blood Donor Month.
Cord Blood America Grand Opening on January 22, 2010: Rain or Shine! Thursday, January 21, 2010 @ 8:14PMLAS VEGAS, Jan. 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc.
Cord Blood America Grand Opening on January 22, 2010: Rain or Shine! Thursday, January 21, 2010 @ 5:15PMCord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that the Grand Opening of its Las Vegas corporate office and laboratory, beginning at Noon to 5 p.m. on Friday, January 22, 2010, will occur whether it rains or ...
Report: Worldwide Landscape Of Stem Cell Research Thursday, January 21, 2010 @ 12:57PMA stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions.
Breakthrough discovery could lead to new treatments for a variety of CNS disorders Monday, January 18, 2010 @ 4:06AMA breakthrough discovery by scientists at the University of Kentucky could someday lead to new treatments for a variety of diseases of the brain, spinal cord and the eye.
First Expanded Umbilical-Cord Blood Units Used To Treat Leukemia Sunday, January 17, 2010 @ 1:07PMScientists at Fred Hutchinson Cancer Research Center have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukemia and other blood cancers.In a study published in the Jan.17 edition of Nature Medicine, Colleen Delaney, M.D., and colleagues describe the first use of a method to vastly expand the number of stem/progenitor cells ...
United Spinal Association Reports Positive Results of Stem Cell Transplantation to Treat Multiple Sclerosis: Study May ... Friday, May 8, 2009 @ 10:08AMNEW YORK, May 8 /PRNewswire-USNewswire/ -- An article published in the Summer 2009 edition of Multiple Sclerosis Quarterly Report, a joint publication of United Spinal Association (www.UnitedSpinal.org) and the North American Research Committee on Multiple Sclerosis (NARCOMS), highlights the positive initial results of patients who have improving neurologic function after receiving a stem cell ...
United Spinal Association Reports Positive Results of Stem Cell Transplantation to Treat Multiple Sclerosis: Study May ... Friday, May 8, 2009 @ 7:32AMAn article published in the Summer 2009 edition of Multiple Sclerosis Quarterly Report, a joint publication of United Spinal Association (www.UnitedSpinal.org) and the North American Research Committee on Multiple Sclerosis (NARCOMS), highlights the positive initial results of patients who have improving neurologic function after receiving a stem cell transplant, despite no longer taking any ...
ThermoGenesis Reports Third Quarter Results; Reduces Net Loss by 60 Percent Wednesday, May 6, 2009 @ 7:08PMRANCHO CORDOVA, Calif., May 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp.
The Faith Column Wednesday, May 6, 2009 @ 5:55AMThe progress of the recent update of the Human Fertilisation and Embryology (HFE) Act through Parliament has, perhaps inevitably, generated much controversy, largely due to some of the areas covered by the Act, such as research on human embryos and “saviour siblings”.
Pluristem Therapeutics Announces Major Clinical Site in North Carolina for PLX-PAD Phase-I Trial Tuesday, May 5, 2009 @ 10:05AMNEW YORK----Pluristem Therapeutics Inc. , a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that the Duke University Medical Center, affiliated with Duke University, Durham, North Carolina, will serve as a clinical site for Pluristem's Phase-I clinical trial involving PLX-PAD for patients ...